Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.75% 2.075 2.05 2.10 2.075 1.935 1.98 37,004,946 15:34:20
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -1.1 0.0 - 11

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 10851 to 10870 of 10875 messages
Chat Pages: 435  434  433  432  431  430  429  428  427  426  425  424  Older
DateSubjectAuthorDiscuss
11/6/2021
18:51
When you’ve got the fastest and best pre clinical platform around for antibody and cell development you might as well focus on your products that are developed in those areas. Amongst the stonking bad CLN and ‘no option taken’ RNS, it’s actually a good decision made by Vlad that has been overlooked by Joe Public.
chimpychops81
11/6/2021
15:29
Nice reversal very bullish sign!
tonytony4
11/6/2021
15:00
Hu-PHEC is going to involve construction/building/manufacturing etc, it was supposed to be a collaboration and was expected to come with a government grant, covid ground it to a halt. Latest update was: The Company's subsidiary in Belgium, Hemogenyx-Cell SPRL, has been considering plans with a number of potential Belgian-based partners, including Orgenesis, Inc. regarding key building blocks for the path through development towards clinical trials of Hu-PHECs, including the establishment of a cell bank. It is going to take millions and years, I have not written it off by any means but I dont think its going to happen this year, they may get an agreement this year, but its going to take time.
justhereforhemo
11/6/2021
14:51
Huphec definitely will be slow to get to market, if they never start the process! I asked the question about Huphec in advance of the webinar last year after discovering documents/webpages that suggested nothing whatsoever had yet happened in Hemogenyx-cell in Belgium. He confirmed this in the webinar without giving any details.
on target
11/6/2021
14:45
Huphec more expensive and slower to get to market. At least Vlad has made one good commercial decision in prioritising SAFE HEMO CAR T and CDX and moving Huphec to the back of the queue for now. I reckon even CBR has passed it in term is of its development timeline and it’s barely been alive a year!
chimpychops81
11/6/2021
11:43
Chimpy you forgot about HuPec.......mind you it seems like Orgenesis have as well.........
badger60
11/6/2021
10:23
CLNs are done Badger. Probably time to move on. Are you shorting if you believe HEMO will move down from here? PENN currently completing IND enabling studies. They will submit an IND app to FDA and will approved at some point. What’s the share price then? HEMO come back to confirm in a collab with Eli on CDX through to trials? What’s that do to the SP? CBR has 2 product candidates already that are moving through pre clinicals. A positive update on those and the share price Tanks? A lupus partner (J&J or Eli) announces a new candidate developed on our lupus disease modelled mice so we are due royalties? Will this hammer the share price down also? All of these things are pretty likely to happen. I do not believe that you believe your own BS. You’re apparently too smart for that... or so I thought.
chimpychops81
11/6/2021
10:00
Don't worry Mint won't covert the CLN......just keep on buying.....baa baa baa
badger60
11/6/2021
09:15
badger60 - 10 Jun 2021 - 04:27:01 - 5938 of 5974 HEMO - HEMO I know that shareholders have had a very tough time of it over the past months but it seems like Hemocasino has attracted more people who are willing to invest. I still hold the same bearish opinion, but also would be happy to be proved wrong as I take no pleasure in seeing people lose significant amounts of money. So good luck and you will only hear from me on a regular basis here if things start to significantly reverse. It is now up to MadVlad to perform, which quite frankly on the corporate side he has failed miserably. To my mind it is imperative that he also secures funding enough to progress product development without repeating the "CLN effect" on shareholder value. You managed what? an hour?
justhereforhemo
11/6/2021
05:18
My guess is 0-3pps.......
badger60
11/6/2021
05:16
Dear oh dear...jhfh forecasting a min share price of 180 p in 12-18 months time......just when you thought that he couldn't post any more worse inane drivel......
badger60
11/6/2021
01:53
ChimpThis is the same jhfh that said Mint wouldn't convert, and received giveaway shares at 1.5 p while not other shareholder got a look in.......
badger60
11/6/2021
01:49
JhfhFunnily enough, I was also posting that ely, big pharma, would not take up CDX. That was lambasted by the flock of sheep as well.
badger60
11/6/2021
01:44
scmlYou should seriously consider changing your avatar to "smell"......it would be far more apt...
badger60
11/6/2021
01:41
Not a strong close today. Is this the start of the downtrend that I mentioned earlier? Struggling to maintain 2pps.....
badger60
10/6/2021
16:51
Badger, you read both of my posts, and your response proves it, not interested in starting up old rivalries, because as I have said its irrelevant now Mint are gone.
justhereforhemo
10/6/2021
15:32
Confine your posts to 2 or 3 sentences as they are very tedious and boring to read.....and contain inane drivel the longer that they go on. Yawn.....
badger60
10/6/2021
13:49
And badger, lets just play out your scenario a bit here. You wanted to save everyone and have all shareholders sell? What exactly does that do to the company? Your saying I cost alot of people money? When your the one who shorted and tried to get people to sell? What about the people who dont sell? Lets say you had been successful and convinced 20 shareholders to dump, what happens to the SP? It tanks, Mint STILL go on to convert but now they are converting at 2-3p right from the start. Were you only trying to save your loyal followers? You do get how the stock market works right? Your argument does not hold water, if you wanted to save everyone the only way to do that is to keep the share price high and minimise the dilution and allow Mint to exit with least amount of damage. Like seriously, how on earth do you think convincing people to sell is going to save all shareholders money?
justhereforhemo
10/6/2021
13:38
JhfYour egotistical ignorant posting about CLNs cost a lot of people a lot of money. You must feel very proud of yourself...,
badger60
10/6/2021
13:29
The share price tanked because Eli Lilly decided not to licence CDX. The CLNs just exacerbated the fall.
on target
Chat Pages: 435  434  433  432  431  430  429  428  427  426  425  424  Older
ADVFN Advertorial
Your Recent History
LSE
HEMO
Hemogenyx ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210612 15:31:53